The Clear Aligner Market Just Fractured. Invisalign Is Losing Ground.

Align Technology collected an average of $1,260 per Invisalign case in the second quarter of 2026, up from $1,250 a year earlier, a raise of $10 on a product whose maker just told investors that pricing for the full year will be flat to slightly down. That is not a company with pricing power. That is a company holding a line, and the reason it can't push harder is buried in the same release: total clear aligner volume grew 7.4%, driven by double-digit expansion across APAC, EMEA and Latin America, with performance in North America described as stable. Stable means flat. Align is growing in every region except the one your patients live in.

Here is the claim, and plenty of owners will argue with it: the Invisalign brand premium has stopped doing work for the average general practice in the United States, and if you're still paying full freight for it on every case, you're subsidizing a consumer marketing engine that is no longer producing volume in your ZIP code. Our view is that aligners in a GP setting are now a commodity input wrapped in a supervision service, and the practices that figure out which half they're actually selling will take share from the ones that don't.

Flat in North America Is the Whole Story

For a decade the pitch to general dentists was straightforward. Align spent enormous sums teaching consumers to want a specific product by name, patients walked in asking for it, and your case fee captured some of that pre-built demand. You paid a premium per case and you got a marketing partner you didn't have to hire.

That trade only works if the demand generation keeps generating. A flat North American volume quarter inside a company posting 7.4% total growth tells you the domestic top of funnel has stopped widening. The growth is real, it's just happening in markets where aligner penetration is still early and where the brand is doing what it did here in 2016. Meanwhile, the geographic mix that produces the growth is exactly what pulls the average selling price down, which is why the company is guiding price flat to slightly lower for the year.

Read that as an operator, not an investor. Your supplier is telling you that the per-case cost you're paying is roughly the ceiling, and the brand pull that justified it domestically has plateaued. You still have a fine product. You no longer have a growth partner in your market.

Eight States Redrew the Board

The second fracture is legal, and it moved faster than most owners noticed. Eight states now require an in-person examination by a dentist or orthodontist before orthodontic treatment can begin: Nevada, Florida, Illinois, Utah, Georgia, West Virginia, Oklahoma, and Texas, where HB4070 took effect on September 1, 2025, per the American Association of Orthodontists. The driver is clinical damage. The AAO reports that 77% of surveyed members have seen patients returning for retreatment after using direct-to-consumer companies without an initial examination.

Organized dentistry has been pushing the same direction. The American Dental Association, speaking for 152,000 member dentists, formally reaffirmed its policy against direct-to-consumer dentistry in December 2023, citing bone loss, lost teeth, receding gums, bite problems and jaw pain as the risks of treatment without in-person supervision.

Put the two fractures side by side. The premium brand is going sideways at home. The cheap mail-order alternative is being legislated into needing a licensed exam, which means needing you. The middle of the market, moderate-cost aligner systems delivered under real clinical supervision, is where the board has opened up. That's the slot, and most practices are not positioned for it because their entire aligner pitch is still built on a brand name they didn't create and can't control.

What Most Owners Get Wrong About Aligner Margin

The specific mistake: owners in general practice track the lab invoice and ignore the fee. They will spend three meetings negotiating a per-case cost down by a hundred dollars and then approve a treatment coordinator's discount script that gives away six times that on the same case, because the discount shows up as "case acceptance" and the lab cost shows up as an expense line.

The people who make this mistake most reliably are owner-dentists who came to aligners through continuing education rather than through practice management, and DSO regional managers running aligner programs off a supply contract. Both are optimizing the input. Neither is defending the output. When a patient walks in with a screenshot of a mail-order price, the fee is the thing that bends, and it bends without anyone calculating what bending costs.

The other half of the mistake is treating clinical time as free because the doctor is salaried or the owner is the doctor. It isn't free. The Bureau of Labor Statistics counts 6,180 orthodontists working in offices of dentists with a mean annual wage of $246,950, or $118.72 an hour. That's the market rate for the supervision you're providing. If your aligner program doesn't clear that hurdle per chair hour, it's a hobby with a lab bill.

Forty Cases, $117,107, and the $600 That Moves It

Take a general practice doing 40 aligner starts a year at a $4,900 case fee. That's $196,000 in aligner production.

Aligner cost at the $1,260 per-case figure Align reported for the quarter runs $50,400 across those 40 cases.

Now price the supervision. Call it six clinical hours per case across records, delivery, monitoring visits, refinements and debond, valued at the BLS orthodontist rate of $118.72 an hour, which is $712.32 of doctor time per case.

Across 40 cases that's $28,492.80 of clinical labor.

Contribution after aligner cost and doctor time comes to $117,107, or $2,928 per case.

Now run the two levers against each other. Lever one is the one everybody pulls: switch half the book, 20 cases, to a system that lands at $900 instead of $1,260. That saves $360 a case.

On 20 cases, that's $7,200 a year.

Lever two is the one nobody guards. Drop the case fee from $4,900 to $4,300 to answer price shoppers, and you give up $600 a case.

Across 40 cases that's $24,000, which is 20.5% of the entire contribution from the program.

So the fee lever is more than three times the size of the supply lever, and it moves in the wrong direction by default, one consult at a time, with nobody signing off. Meanwhile the thing that triggered all this anxiety, Align's $10 year-over-year price increase, costs the practice $400 a year on 40 cases.

That's the whole argument in one number. Owners will hold a vendor meeting over $400 and hand back $24,000 at the front desk.

The Retreatment Channel Nobody Is Marketing To

The 77% figure from the AAO survey is usually quoted as an indictment of mail-order aligners. Treat it as a demand signal instead. Three-quarters of surveyed orthodontists are already seeing these patients come back. Those patients have demonstrated that they want their teeth straightened, they've already spent money on it, and they now have a clinical problem that requires a licensed exam in a growing list of states.

Price it. Say six retreatment cases a year at $5,600, because these are harder and you should charge for that. That's $33,600.

Aligner cost at $1,260 runs $7,560 across the six.

Give them eight clinical hours each instead of six, which at $118.72 is $949.76 per case and $5,698.56 total.

Contribution: $20,341.

Stack that on the base program and the aligner line clears $137,448 in contribution on 46 cases.

Six cases. That's one a quarter plus two, from a patient group that is currently being served by referral accident rather than by anybody's marketing plan. We'd build the campaign before we'd renegotiate the supply contract.

Our Call: Stop Paying for the Brand, Start Charging for the Exam

Here's where we'll commit. We would not run a general practice aligner program that pays a premium per case for consumer brand pull in a market where that brand's volume is flat. Keep Invisalign for the complex cases and the patients who walk in asking for it by name, because brand-requested cases are the ones where the premium still converts. Move the straightforward crowding and relapse cases to a lower-cost system and keep the difference, because the patient in that chair is buying a result and a doctor, not a logo.

And we would not cut the case fee. Not by $600, not by $300. Every state that mandates an in-person exam before treatment is a state where your license became the gating item for an entire category of competitor. That's not a moment to discount. The ADA has 152,000 dentists on record saying the unsupervised version of this is dangerous, and eight legislatures have now agreed in statute. You're not selling plastic. You're selling the exam, the monitoring and the liability you carry when something moves wrong, and a mail-order box cannot ship any of that.

Four Moves Before Your Next Aligner Consult

Pull your last 12 months of aligner cases this week and calculate the average collected fee against your posted fee; the gap is your real discount rate and it probably isn't on any report you read. Split your case list into brand-requested and doctor-recommended, then price a second, lower-cost system for the doctor-recommended half only. Write a two-sentence retreatment script for the front desk and a short page on your site for patients who started with a mail-order company and stopped. Then set a floor fee in writing and take discount authority away from anyone who isn't you.

We're watching three things from here: whether states nine and ten land in 2026, whether Align guides North American volume down rather than flat on the next call, and whether the large DSO groups move to private-label aligners at scale, which would reprice the whole middle of the market within four quarters. What would change our position is simple. If North American volume turns back to mid-single-digit growth with the average selling price holding, the brand is still buying demand and the premium is worth paying again. Until then, it's a line item.

If you want to see where your aligner program actually sits against your fixed costs and doctor time, the overhead calculator will take your production, lab spend and clinical hours and give you a per-chair-hour contribution number you can hold a fee floor against. Run your own numbers before the next consult talks you down $600.